Healthcare Scan
Scan
Healthcare Scan
raw scan snapshot — prices as of scan date, not live 32 rows · screens, not recommendations superseded by2026-04-26-healthcare-scanported fromresearch/classic/scans/_archive/2026-04-03-healthcare-scan.mdscan slughealthcare-scansource typescan-archive
Healthcare selling off broadly: med-tech (ISRG, DXCM, ABT) approaching oversold, UNH in crisis mode (-54% from high). Pharma defensives (JNJ, PFE, MRK) and MRNA are bright spots.
Quick Snapshot
| Signal | Reading |
|---|---|
| Overall | 🟡 Mixed — pharma defensives strong, med-tech and managed care in trouble |
| Leaders | MRNA (+46.7% vs SMA200), JNJ (+23.6%), MRK (+27.2%), GRDN (+35.9%) |
| Laggards | UNH (-54% from high), VEEV (-30.2% vs SMA200), DXCM (RSI 33), ABT (RSI 33) |
Price Table
| Stock | Price | RSI | vs SMA20 | 7D% | 30D% | 3M% | Trend | Signal |
|---|---|---|---|---|---|---|---|---|
| SYK | $331.54 | 38.3 | -2.2% | +1.05% | -13.56% | -4.69% | strong-down | 🔍 Research |
| ISRG | $452.07 | 32.9 | -4.7% | -0.79% | -9.12% | -20.18% | strong-down | 🔍 Research |
| MDT | $86.63 | 38.6 | -0.6% | -0.02% | -9.69% | -10.29% | down | 🔍 Watch |
| DXCM | $62.22 | 32.8 | -5.2% | -1.50% | -14.86% | -8.03% | strong-down | 🔍 Research |
| ABT | $102.87 | 33.4 | -3.5% | -0.84% | -9.45% | -18.23% | strong-down | 🔍 Research |
| PFE | $28.32 | 61.9 | +3.8% | +3.02% | +6.55% | +14.38% | strong-up | 🔒 Hold |
| MRK | $120.87 | 61.7 | +3.4% | +1.12% | +1.61% | +13.33% | strong-up | 🔒 Hold |
| LLY | $935.58 | 46.4 | -0.6% | +5.41% | -7.16% | -10.02% | weak-down | 🔍 Watch |
| GILD | $139.71 | 47.5 | -0.9% | +1.93% | -4.96% | +18.77% | weak-down | 🔍 Watch |
| AMGN | $347.94 | 40.0 | -2.9% | -1.36% | -7.71% | +9.24% | weak-down | 🔍 Watch |
| BIIB | $177.34 | 40.7 | -4.1% | -5.22% | -3.63% | +1.55% | weak-down | 🔍 Watch |
| JNJ | $243.04 | 57.7 | +1.1% | +0.27% | -1.50% | +19.59% | strong-up | 🔒 Hold |
| UNH | $277.26 | 49.1 | +0.2% | +5.56% | -3.39% | -18.30% | strong-down | ⚠️ Caution |
| CVS | $73.49 | 47.6 | -0.2% | +3.81% | -8.70% | -7.86% | down | 🔍 Watch |
| VEEV | $173.98 | 39.0 | -4.5% | +0.07% | -6.42% | -21.39% | strong-down | 🔍 Research |
| TMO | $491.46 | 47.6 | +1.6% | +2.89% | -3.18% | -19.51% | down | 🔍 Watch |
| VRTX | $438.71 | 40.4 | -4.3% | -1.58% | -7.50% | -2.25% | weak-down | 🔍 Watch |
| MRNA | $49.20 | 46.5 | -5.9% | -4.54% | -1.26% | +52.94% | strong-up | 🔒 Hold |
| ZTS | $117.94 | 46.4 | +0.3% | +2.96% | -6.34% | -8.45% | strong-down | ⚠️ Caution |
| GRDN | $37.99 | 63.5 | +8.6% | +11.00% | +11.60% | +21.84% | strong-up | 🔒 Hold |
Entry Zones
| Stock | Entry Zone | RSI | Thesis |
|---|---|---|---|
| ISRG | <$460 | 32.9 | Surgical robotics monopoly, -25% from high |
| DXCM | <$65 | 32.8 | CGM leader, -31% from high, approaching capitulation |
| ABT | <$105 | 33.4 | Diversified med-tech, -26% from high |
| SYK | <$335 | 38.3 | Orthopedic leader, -18% from high |
| VEEV | <$175 | 39.0 | Healthcare cloud, -44% from high |
Action Matrix
| Action | Stocks | Why |
|---|---|---|
| 🔒 HOLD | JNJ, PFE, MRK, MRNA, GRDN | Pharma defensives + momentum |
| 🔍 RESEARCH | ISRG, DXCM, ABT, SYK, VEEV | Approaching oversold, high quality |
| 🔍 WATCH | LLY, GILD, TMO, AMGN | Mid-range, monitoring |
| ⚠️ CAUTION | UNH, ZTS | Fundamental concerns, broken trends |
Related
10 eventsNo direct external sources are attached to this read.